{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:13:55Z","timestamp":1784052835407,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"French bank of investment BPI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00520-026-10878-6","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:16:56Z","timestamp":1781237816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TAR-0520, a new candidate in oncodermatology: Results of a phase 1 program in healthy volunteers"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-8099","authenticated-orcid":false,"given":"Philippe","family":"Andres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Winckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lamquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Czernielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"11","key":"10878_CR1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/pon.1847","volume":"20","author":"S Coleman","year":"2010","unstructured":"Coleman S, Kovtun I, Nguyen PL, Pittelkow M, Jatoi A (2010) A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors. Psychooncology 20(11):1246\u20131249","journal-title":"Psychooncology"},{"issue":"1","key":"10878_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1188\/05.CJON.103-106","volume":"9","author":"JM Brant","year":"2005","unstructured":"Brant JM, Wilkes GM, Doyle D (2005) Palmar-plantar erythrodysesthesia. Clin J Oncol Nurs 9(1):103\u2013106. https:\/\/doi.org\/10.1188\/05.CJON.103-106","journal-title":"Clin J Oncol Nurs"},{"issue":"11","key":"10878_CR3","first-page":"e61","volume":"11","author":"B Nardone","year":"2012","unstructured":"Nardone B, Hensley JR, Kulik L, West DP, Mulcahy M, Rademaker A, Lacouture ME (2012) The effect of hand foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life. J Drugs Dermatol 11(11):e61\u2013e65","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10878_CR4","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/j.1365-2648.2011.05668.x","volume":"67","author":"M Kargar","year":"2011","unstructured":"Kargar M, Sarvestani RS, Khojasteh HN, Heidari MT (2011) Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 67(11):2473\u20132477. https:\/\/doi.org\/10.1111\/j.1365-2648.2011.05668.x","journal-title":"J Adv Nurs"},{"issue":"Suppl. 16","key":"10878_CR5","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.12968\/bjon.2014.23.sup16.s4","volume":"23","author":"H Roe","year":"2014","unstructured":"Roe H (2014) Scalp cooling: management option for chemotherapy-induced alopecia. Br J Nurs 23(Suppl. 16):S4\u2013S12. https:\/\/doi.org\/10.12968\/bjon.2014.23.sup16.s4","journal-title":"Br J Nurs"},{"issue":"6","key":"10878_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.clindermatol.2020.06.007","volume":"38","author":"D Haynes","year":"2020","unstructured":"Haynes D, Ortega-Loayza AG (2020) Adverse cutaneous reactions to chemotherapeutic drugs. Clin Dermatol 38(6):712\u2013728. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.007","journal-title":"Clin Dermatol"},{"issue":"5","key":"10878_CR7","doi-asserted-by":"publisher","first-page":"E149","DOI":"10.1188\/20.ONF.E149-E160","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Farah MH, Nayfeh T, Balandras K, Manolopoulos A, Ginex PK et al (2020) Targeted therapy- and chemotherapy-associated skin toxicities: Systematic review and meta-analysis. Oncol Nurs Forum 47(5):E149\u2013E160. https:\/\/doi.org\/10.1188\/20.ONF.E149-E160","journal-title":"Oncol Nurs Forum"},{"issue":"5","key":"10878_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1188\/20.ONF.539-556","volume":"47","author":"LA Williams","year":"2020","unstructured":"Williams LA, Ginex PK, Ebanks GL Jr, Ganstwig K, Ciccolini K, Kwong BK et al (2020) ONS Guidelines\u2122 for cancer treatment-related skin toxicity. Oncol Nurs Forum 47(5):539\u2013556. https:\/\/doi.org\/10.1188\/20.ONF.539-556","journal-title":"Oncol Nurs Forum"},{"key":"10878_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2024.06.012","volume":"188","author":"KA Lambert","year":"2024","unstructured":"Lambert KA, Albright BB, Anastasio MK, Kaplan SJ, McNally L (2024) Scalp hypothermia to reduce chemotherapy-induced alopecia: a systematic review and meta-analysis. Gynecol Oncol 188:71\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.012","journal-title":"Gynecol Oncol"},{"key":"10878_CR10","doi-asserted-by":"publisher","unstructured":"Gen\u00e7 Z, Kebap\u00e7\u0131 A, Can G (2025) The effect of cold therapy on the prevention of chemotherapy-induced peripheral neuropathy in oncology patients: a systematic review study. Semin Oncol Nurs 41(3):151849, 151849. https:\/\/doi.org\/10.1016\/j.soncn.2025.151849","DOI":"10.1016\/j.soncn.2025.151849"},{"issue":"8","key":"10878_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00520-025-09689-y","volume":"33","author":"T Mallela","year":"2025","unstructured":"Mallela T, Kaufman L, Dulmage B (2025) Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review. Support Care Cancer 33(8):678. https:\/\/doi.org\/10.1007\/s00520-025-09689-y","journal-title":"Support Care Cancer"},{"issue":"2","key":"10878_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","volume":"32","author":"ME Lacouture","year":"2021","unstructured":"Lacouture ME, Sibaud V, Gerber PA, van den Hurk C, Fern\u00e1ndez-Pe\u00f1as P, Santini Dea et al (2021) Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines\u2606. Ann Oncol 32(2):157\u2013170. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.005","journal-title":"Ann Oncol"},{"issue":"1","key":"10878_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jdermsci.2014.04.002","volume":"75","author":"D Piwnica","year":"2014","unstructured":"Piwnica D, Rosignoli C, de M\u00e9nonville ST, Alvarez T, Schuppli Nollet M, Roye O, Jomard A, Aubert J (2014) Vasoconstriction and anti-inflammatory properties of the selective \u03b1-adrenergic receptor agonist brimonidine. J Dermatol Sci 75(1):49\u201354. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.04.002","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10878_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40268-018-0227-y","volume":"18","author":"D Piwnica","year":"2018","unstructured":"Piwnica D, Pathak A, Sch\u00e4fer G, Docherty JR (2018) In vitro safety pharmacology profiling of topical \u03b1-adrenergic agonist treatments for erythema of rosacea. Drugs R D 18(1):87\u201390. https:\/\/doi.org\/10.1007\/s40268-018-0227-y","journal-title":"Drugs R D"},{"key":"10878_CR15","unstructured":"EMA\/CHMP\/115246\/2014 Mirvaso assessment report. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/mirvaso-epar-public-assessment-report_en.pdf. Accessed 19 November 2025."},{"issue":"3","key":"10878_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2133.1991.tb00571.x","volume":"124","author":"C Queille-Roussel","year":"1991","unstructured":"Queille-Roussel C, Poncet M, Schaefer H (1991) Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. Br J Dermatol 124(3):264\u2013270. https:\/\/doi.org\/10.1111\/j.1365-2133.1991.tb00571.x","journal-title":"Br J Dermatol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10878-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:02:54Z","timestamp":1784052174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10878-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10878"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10878-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this publication are the founders of Tarian Pharma, the company developing the test product used in the two clinical trials in this publication.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The two reported studies were performed in line with the principles of the Declaration of Helsinki. Approval of the first study was granted by the Ethics Committee \u201cCPP Sud-M\u00e9diterran\u00e9en 4\u201d from Montpellier. Approval of the second study was granted by the Ethics Committee \u201cClinical Research Regulatory Council (CRRC)\u201d from the Republic of Mauritius.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the two studies.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No individual details, images or videos are included in this manuscript.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"649"}}